Cover Image

Perioperative outcomes and complication rates in holmium laser enucleation of the prostate patients after prior prostate biopsy: does it really make a difference? A propensity score matched analysis

Introduction: Before holmium laser enucleation of the prostate (HoLEP), many patients have undergone short-term prostate biopsy (PB) to rule out the presence of prostate cancer. The aim of this study is to determine whether a short-term PB before HoLEP has an impact on the perioperative outcomes or...

Full description

Saved in:
Bibliographic Details
Main Authors: Hartung, Friedrich (Author) , Egen, Luisa (Author) , Grüne, Britta (Author) , Netsch, Christopher (Author) , Patroi, Paul (Author) , Kriegmair, Maximilian (Author) , Hardenberg, Jost von (Author) , Rassweiler-Seyfried, Marie-Claire (Author) , Michel, Maurice Stephan (Author) , Wenk, Maren (Author) , Herrmann, Jonas (Author)
Format: Article (Journal)
Language:English
Published: 16 July 2024
In: Journal of endourology
Year: 2024, Volume: 38, Issue: 7, Pages: 675-681
ISSN:1557-900X
DOI:10.1089/end.2024.0008
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1089/end.2024.0008
Verlag, lizenzpflichtig, Volltext: https://www.liebertpub.com/doi/10.1089/end.2024.0008
Get full text
Author Notes:Friedrich Otto Hartung, Luisa Egen, Britta Grüne, Christopher Netsch, Paul Patroi, Maximilian Christian Kriegmair, Jost von Hardenberg, Marie-Claire Rassweiler-Seyfried, Maurice Stephan Michel, Maren Julianne Wenk and Jonas Herrmann
Description
Summary:Introduction: Before holmium laser enucleation of the prostate (HoLEP), many patients have undergone short-term prostate biopsy (PB) to rule out the presence of prostate cancer. The aim of this study is to determine whether a short-term PB before HoLEP has an impact on the perioperative outcomes or complications of HoLEP. - Methods: In total, 734 consecutive patients treated with HoLEP at a tertiary care university hospital between January 2021 and July 2023 were retrospectively enrolled. Patients who had PB within 6 months before HoLEP were matched to patients who underwent PB more than 6 months or had no PB before HoLEP using propensity score matching (PSM) based on age, prostate volume (PV), prostate-specific antigen (PSA), preoperative urinary tract infection (UTI), and surgeon. Perioperative parameters, such as operation time (OT), enucleation efficiency (EF), as well as complications according to the Satava classification, the Clavien-Dindo classification (CDC), and the Comprehensive Complication Index (CCI) were evaluated. - Results: In total, 206 patients were matched. Age, PV, PSA, as well as the presence of a preoperative UTI and surgeons did not differ significantly between both groups after PSM. There were no significant differences in mean OT (75 vs. 81 minutes, p = 0.28) and EF (2.13 vs. 2.13 g/min, p = 0.99). No differences were noted regarding intraoperative (16 vs. 25, p = 0.16) or postoperative complications graded by CDC (p = 0.53) and CCI (p = 0.92). - Conclusion: PB within 6 months preoperatively before HoLEP showed no effect on perioperative outcomes or intra- and postoperative complications.
Item Description:Gesehen am 13.02.2025
Physical Description:Online Resource
ISSN:1557-900X
DOI:10.1089/end.2024.0008

Similar Items